Replimune Group, Inc. (REPL) Marks A 4.26% Move Today, Would Now Be A Good Time To Sell?

Replimune Group, Inc. (NASDAQ:REPL) is among the top stocks that may remain in focus today as the company shares are trading 4.26% or 0.52 points lower from last closing price of $12.2, reaching $11.68 at last check. Any clue why there is so much of action in the REPL stock? The share price is losing for the second day in a row and has dropped in 4 of the last 5 days and is up 9.52% over the past week. It will be exciting to see whether the stock manages to continue decreasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -714,313 shares, and in total 105487 shares valued at $1.232 million were seen changing hands compared with 819800 shares valued at $10.002 million recorded at the previous session. You should take into consideration that a falling volume on lower prices shows the bearish trend but this is an early indication which means that the REPL stock is near its bottom.

Replimune Group, Inc. (REPL) shares have notched a 3-month gain of about 9.52%, but has still advanced 22% year to date. By comparison, the stock sank -13.35% over the past 12 months, while it slipped -15.57% over the 1 month. The company’s market cap is around $436.64M, with its short interest ratio standing at 6.35%.

In the current trading session for REPL, the stock witnessed two major price actions, it rose to a high of $12.4 and was down as much as $11.55 at one point. The high recorded is very low when compared to their 52-week high which is $8.88. The 52-week high is now at -36.27 distance from current price. Their recent low of $18.25 represents a 30.97% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for REPL is $28.57, this is above the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.

REPL‘s last price was down -14.35% as compared to the average trading price of 50 days recorded at $13.64 while enlarging the period to 200 trading days, the average closing price was $14.29. At present, there are 35.79 million in the total number of common shares owned by the public and among those 26.38 million shares have been available to trade. The percentage of shares being held by the company management was 14.6% while institutions stake was 87.9%. The company has generated negative returns on equity over the last 12 months (-26.3%). It managed to keep its gross profit margin at 0% over the past 12 months.

When assessing the full upside of the REPL stock, there is another set of technicals that should be looked into and considered. Its -26.4% decline from moving average of $15.87 has brought about a negative sentiment when calculated over the last 20 days. The market has allocated a beta of 0 to the stock. With the beta been less than one, this implies that the company shares are theoretically less volatile than the market, something that the traders definitely are keeping an eye on.

Most of the analysts surveyed by Thomson/First Call think quite highly of Replimune Group, Inc. — 5 analysts rate the stock as a buy with another 0 rating it strong buy. There are 0 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $26.8 on shares of Replimune Group, Inc. (NASDAQ:REPL), which corresponds to 129.45% upside potential than its current market price of $11.68 and implies potential despite the recent drop in the price. However, their current target price has climbed from $24.8 a month ago and is up handily from the consensus target of $26 a quarter ago.

Let’s briefly check the hedge fund interest towards REPL stock. Emerald Mutual Fund Advisers Trust added position in the company after it grew 3% or 712,043 shares of its common stock. The hedge fund now owns 733,404 shares worth $8,566,159, SEC documents show. Emerald Advisers LLC shored up assets in the stock as 692861.2 shares have been purchased, increasing its stake by 5.2% to 728,890 shares which are currently valued at $8,513,435. In addition, Victory Capital Management Inc. recently reported that it now owns 167,180 shares making a total of $1,952,662 based on the recent price. This refelects a change of -5.6% in their ownership.